Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone

Home

Mutual Funds

Nippon India Pharma Fund

Nippon India Pharma Fund icon

Nippon India Pharma Fund

Sectoral-PharmaRank #25
3/5

NAV (2026-08-28)

577.58

AUM

₹9,279.11 Cr

Exp. Ratio: 1.84%

RISK LEVEL

Very High

Returns & Performance

1 Year13.61%5.42% vs cat avgRank #23
3 Year18.39%3.38% vs cat avgRank #15
5 Year13.41%1.25% vs cat avgRank #9
Since Launch20.00%2.80% vs cat avg

Fund vs Category Average

1Y
13.61%-5.42%
3Y
18.39%-3.38%
5Y
13.41%-1.25%

Pros & Cons

Pros

No lock-in period
Outperforms category avg since launch

Cons

1Y returns trail category average
3Y returns below category average
5Y returns below category average
Higher expense ratio (1.84%)
1Y category rank outside top 15 (#23)
Overall rank #25 in category
ISININF204K01968
NAV₹577.58
NAV Date2026-08-28
AUM₹9,279.11 Cr
Expense Ratio1.84%
RiskVery High
Rating3 / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.1995-06-30

INVESTMENT OBJECTIVE

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Exit Load1.00%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.

Amber Singhania

MMS Finance (Mumbai University)

Prior to joining the Nippon India AMC, he was associated with Asian Markets Securities Pvt. Ltd.

Top Holdings

CompanySectorAsset Value (Cr)Asset %
Sun Pharmaceutical Industries Ltd.Healthcare₹1235.3713.31
Lupin Ltd.Healthcare₹672.337.25
Divi's Laboratories Ltd.Healthcare₹604.816.52
Cipla Ltd.Healthcare₹559.096.03
Dr. Reddy's Laboratories Ltd.Healthcare₹472.635.39
Apollo Hospitals Enterprise Ltd.Healthcare₹491.565.30
Dr. Reddy's Laboratories Ltd.Healthcare₹464.955.01
Mankind Pharma Ltd.Healthcare₹346.843.74
Sai Life Sciences Ltd.Healthcare₹336.113.62
Ajanta Pharma Ltd.Healthcare₹316.693.41

Frequently Asked Questions

Common questions about this fund, answered from scheme data

The latest Net Asset Value (NAV) of Nippon India Pharma Fund is ₹577.58 as of 2026-08-28.

The FAQs above are generated from data provided by the AMC and are for educational purposes only. They do not constitute financial advice, buy/sell recommendations, or return guarantees. Mutual fund investments are subject to market risks — read all scheme-related documents carefully before investing. Past performance is not indicative of future returns.